KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) Equity Ratio (2011 - 2026)

Repligen (RGEN) reported Equity Ratio of 0.72 for Q1 2026, up 3.2% year-over-year from 0.7 in Q1 2025, and up 0.61% on a QoQ basis from 0.71 in Q4 2025.

Repligen (RGEN) has 16 years of Equity Ratio data on file, last reported at 0.72 in Q1 2026.

  • Quarterly Equity Ratio rose 3.2% year-over-year to 0.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.72 (up 3.2% YoY) and the FY2025 annual result came in at 0.71, up 2.42% from the prior year.
  • Equity Ratio improved to 0.72 in Q1 2026 per RGEN's latest filing, from 0.71 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.78 in Q3 2023 and bottomed at 0.69 in Q1 2024.
  • The 5-year median for Equity Ratio is 0.71 (2025), against an average of 0.72.
  • The widest annual swing landed in 2023, when Equity Ratio rose 4.99%; it then retreated 9.52% in 2024.
  • Tracing RGEN's Equity Ratio over 5 years: stood at 0.75 in 2022, then slipped by 8.05% to 0.69 in 2023, then grew by 0.45% to 0.7 in 2024, then rose by 2.42% to 0.71 in 2025, then increased by 0.61% to 0.72 in 2026.
  • Per Business Quant, the three latest RGEN Equity Ratio figures stand at 0.72 (Q1 2026), 0.71 (Q4 2025), and 0.71 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.88
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.47
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.73
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.35
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.67
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.66
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.30
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.52
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn 0.72

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.72
Dec 31, 2025 0.71
Sep 30, 2025 0.71
Jun 30, 2025 0.71
Mar 31, 2025 0.70
Dec 31, 2024 0.70
Sep 30, 2024 0.71
Jun 30, 2024 0.69
Mar 31, 2024 0.69
Dec 31, 2023 0.69
Sep 30, 2023 0.78
Jun 30, 2023 0.77
Mar 31, 2023 0.76
Dec 31, 2022 0.75
Sep 30, 2022 0.75
Jun 30, 2022 0.74
Mar 31, 2022 0.74
Dec 31, 2021 0.74
Sep 30, 2021 0.77
Jun 30, 2021 0.80
Mar 31, 2021 0.81
Dec 31, 2020 0.80
Sep 30, 2020 0.76
Jun 30, 2020 0.76
Mar 31, 2020 0.76
Dec 31, 2019 0.76
Sep 30, 2019 0.76
Jun 30, 2019 0.82
Mar 31, 2019 0.78
Dec 31, 2018 0.79
Sep 30, 2018 0.80
Jun 30, 2018 0.80
Mar 31, 2018 0.80
Dec 31, 2017 0.80
Sep 30, 2017 0.79
Jun 30, 2017 0.62
Mar 31, 2017 0.61
Dec 31, 2016 0.58
Sep 30, 2016 0.58
Jun 30, 2016 0.58
Mar 31, 2016 0.87
Dec 31, 2015 0.84
Sep 30, 2015 0.87
Jun 30, 2015 0.86
Mar 31, 2015 0.87
Dec 31, 2014 0.87
Sep 30, 2014 0.89
Jun 30, 2014 0.90
Mar 31, 2014 0.91
Dec 31, 2013 0.71
Sep 30, 2013 0.90
Jun 30, 2013 0.88
Mar 31, 2013 0.90
Dec 31, 2012 0.87
Sep 30, 2012 0.87
Jun 30, 2012 0.84
Mar 31, 2012 0.85
Dec 31, 2011 0.87
Sep 30, 2011 0.93
Jun 30, 2011 0.94
Mar 31, 2011 0.93